The stock of Sana Biotechnology Inc (SANA) has gone down by -8.38% for the week, with a -32.95% drop in the past month and a -53.46% drop in the past quarter. The volatility ratio for the week is 11.36%, and the volatility levels for the past 30 days are 11.61% for SANA. The simple moving average for the last 20 days is -20.44% for SANA’s stock, with a simple moving average of -69.38% for the last 200 days.
Is It Worth Investing in Sana Biotechnology Inc (NASDAQ: SANA) Right Now?
Company’s 36-month beta value is 1.40.Analysts have differing opinions on the stock, with 2 analysts rating it as a “buy,” 2 as “overweight,” 3 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for SANA is 122.43M, and currently, short sellers hold a 30.08% ratio of that floaft. The average trading volume of SANA on December 26, 2024 was 1.67M shares.
SANA) stock’s latest price update
Sana Biotechnology Inc (NASDAQ: SANA)’s stock price has soared by 7.36 in relation to previous closing price of 1.63. Nevertheless, the company has seen a loss of -8.38% in its stock price over the last five trading days. accesswire.com reported 2024-12-24 that NEW YORK, NY / ACCESSWIRE / December 24, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Sana Biotechnology, Inc. (“Sana” or the “Company”) (NASDAQ:SANA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
Analysts’ Opinion of SANA
Rodman & Renshaw, on the other hand, stated in their research note that they expect to see SANA reach a price target of $16. The rating they have provided for SANA stocks is “Buy” according to the report published on June 26th, 2024.
H.C. Wainwright gave a rating of “Buy” to SANA, setting the target price at $12 in the report published on January 16th of the current year.
SANA Trading at -38.85% from the 50-Day Moving Average
After a stumble in the market that brought SANA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -85.42% of loss for the given period.
Volatility was left at 11.61%, however, over the last 30 days, the volatility rate increased by 11.36%, as shares sank -29.44% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -56.36% lower at present.
During the last 5 trading sessions, SANA fell by -8.38%, which changed the moving average for the period of 200-days by -81.58% in comparison to the 20-day moving average, which settled at $2.1992. In addition, Sana Biotechnology Inc saw -57.11% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at SANA starting from CHRISTIAN HORDO & KATHARINE HO, who proposed sale 75,000 shares at the price of $1.89 back on Dec 16 ’24. After this action, CHRISTIAN HORDO & KATHARINE HO now owns shares of Sana Biotechnology Inc, valued at $141,750 using the latest closing price.
Hardy Nathan, the Former CFO of Sana Biotechnology Inc, proposed sale 91,607 shares at $2.50 during a trade that took place back on Nov 26 ’24, which means that Hardy Nathan is holding shares at $229,018 based on the most recent closing price.
Stock Fundamentals for SANA
The total capital return value is set at -0.58. Equity return is now at value -92.90, with -51.36 for asset returns.
Currently, EBITDA for the company is -252.39 million with net debt to EBITDA at 0.11. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.47.
Conclusion
In a nutshell, Sana Biotechnology Inc (SANA) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.